MC Nicolson

1.6k total citations · 1 hit paper
20 papers, 1.2k citations indexed

About

MC Nicolson is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Surgery. According to data from OpenAlex, MC Nicolson has authored 20 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Oncology, 8 papers in Pulmonary and Respiratory Medicine and 4 papers in Surgery. Recurrent topics in MC Nicolson's work include Lung Cancer Research Studies (5 papers), Lung Cancer Treatments and Mutations (4 papers) and Esophageal Cancer Research and Treatment (3 papers). MC Nicolson is often cited by papers focused on Lung Cancer Research Studies (5 papers), Lung Cancer Treatments and Mutations (4 papers) and Esophageal Cancer Research and Treatment (3 papers). MC Nicolson collaborates with scholars based in United Kingdom, United States and Canada. MC Nicolson's co-authors include David Cunningham, Tamas Hickish, Janine Mansi, A. Norman, Andrew Webb, Mary O’Brien, J. Oates, Andrew Hill, J.H. Scarffe and Craig Underhill and has published in prestigious journals such as Journal of Clinical Oncology, Gastroenterology and British Journal of Cancer.

In The Last Decade

MC Nicolson

20 papers receiving 1.2k citations

Hit Papers

Randomized trial comparing epirubicin, cisplatin, and flu... 1997 2026 2006 2016 1997 200 400 600
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Randomized trial comparing epirubicin, cisplatin, and fluorouracil versus fluorouracil, doxorubicin, and methotrexate in advanced esophagogastric cancer.
    1997 691 citations Andrew Webb, David Cunningham et al. Journal of Clinical Oncology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
MC Nicolson United Kingdom 11 980 750 454 217 119 20 1.2k
Michitaka Nagase Japan 18 836 0.9× 640 0.9× 666 1.5× 161 0.7× 81 0.7× 51 1.3k
U. Fink Germany 13 435 0.4× 402 0.5× 405 0.9× 115 0.5× 137 1.2× 26 901
Motonori Sairenji Japan 16 812 0.8× 314 0.4× 457 1.0× 329 1.5× 123 1.0× 68 1.1k
D. P. Kelsen United States 17 689 0.7× 426 0.6× 579 1.3× 55 0.3× 134 1.1× 39 1.1k
John C. McAuliffe United States 14 429 0.4× 326 0.4× 408 0.9× 346 1.6× 130 1.1× 33 883
Günther Klautke Germany 19 467 0.5× 605 0.8× 456 1.0× 61 0.3× 85 0.7× 69 1.0k
Emmanuelle Samalin France 16 353 0.4× 562 0.7× 201 0.4× 123 0.6× 137 1.2× 75 827
Jacqui Oates United Kingdom 10 464 0.5× 773 1.0× 550 1.2× 100 0.5× 57 0.5× 11 1.1k
Seiichi Takagi Japan 7 1.4k 1.4× 723 1.0× 574 1.3× 671 3.1× 151 1.3× 15 1.7k
Aurore Blesius France 12 352 0.4× 336 0.4× 171 0.4× 163 0.8× 215 1.8× 26 677

Countries citing papers authored by MC Nicolson

Since Specialization
Citations

This map shows the geographic impact of MC Nicolson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by MC Nicolson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites MC Nicolson more than expected).

Fields of papers citing papers by MC Nicolson

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by MC Nicolson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by MC Nicolson. The network helps show where MC Nicolson may publish in the future.

Co-authorship network of co-authors of MC Nicolson

This figure shows the co-authorship network connecting the top 25 collaborators of MC Nicolson. A scholar is included among the top collaborators of MC Nicolson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with MC Nicolson. MC Nicolson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kerr, Keith M., G. Skailes, Vanessa Potter, et al.. (2010). Thymidylate synthetase (TS) immunohistochemistry (IHC): Feasibility in a routine clinical setting for patients receiving treatment with pemetrexed for advanced nonsquamous NSCLC.. Journal of Clinical Oncology. 28(15_suppl). TPS293–TPS293. 2 indexed citations
2.
3.
4.
Hickish, Tamas, MC Nicolson, Sue Ashley, et al.. (1998). A pilot study of MVP (mitomycin-C, vinblastine and cisplatin) chemotherapy in small-cell lung cancer. British Journal of Cancer. 77(11). 1966–1970. 13 indexed citations
5.
Wallis, F., et al.. (1998). The detection of response to chemotherapy using positron emission tomography in patients with oesophageal and gastric cancer. Gastroenterology. 114. A582–A582. 2 indexed citations
6.
Nicolson, MC, et al.. (1997). Continuous infusional topotecan in advanced breast and non-small-cell lung cancer: no evidence of increased efficacy. British Journal of Cancer. 76(12). 1636–1639. 20 indexed citations
7.
Webb, Andrew, David Cunningham, J.H. Scarffe, et al.. (1997). Randomized trial comparing epirubicin, cisplatin, and fluorouracil versus fluorouracil, doxorubicin, and methotrexate in advanced esophagogastric cancer.. Journal of Clinical Oncology. 15(1). 261–267. 691 indexed citations breakdown →
8.
9.
Woodman, C B J, et al.. (1996). Towards quality control in cancer chemotherapy. British Journal of Cancer. 73(1). 117–118. 2 indexed citations
10.
Smith, IE, et al.. (1995). Symptom relief with MVP (mitomycin C, vinblastine and cisplatin) chemotherapy in advanced non-small-cell lung cancer. British Journal of Cancer. 71(2). 366–370. 144 indexed citations
11.
Andreyev, Jervoise, David Cunningham, V Nicolson, et al.. (1995). Phase II study of continuous infusion fluorouracil and interferon alfa-2b in the palliation of malignant neuroendocrine tumors.. Journal of Clinical Oncology. 13(6). 1486–1492. 34 indexed citations
12.
Fernando, Indrajit, T.J. Powles, A G Nash, et al.. (1995). Determining factors which predict response to primary medical therapy in breast cancer using a single fine needle aspirate with immunocytochemical staining and flow cytometry. Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin. 426(2). 155–61. 11 indexed citations
13.
Bamias, Aristotle, David Cunningham, V Nicolson, et al.. (1995). Adjuvant chemotherapy for oesophagogastric cancer with epirubicin, cisplatin and infusional 5-fluorouracil (ECF): a Royal Marsden pilot study. British Journal of Cancer. 71(3). 583–586. 9 indexed citations
14.
Preston, Nancy, Roger A’Hern, Catherine Hill, et al.. (1995). Platinum-Taxol non-cross resistance in epithelial ovarian cancer. British Journal of Cancer. 71(6). 1308–1310. 21 indexed citations
15.
Ellis, PA, et al.. (1995). A pilot study of mitomycin, cisplatin and continuous infusion 5-fluorouracil (MCF) in advanced non-small-cell lung cancer. British Journal of Cancer. 71(6). 1315–1318. 2 indexed citations
16.
17.
Orr, Rosanne M., CF O'Neill, MC Nicolson, et al.. (1994). Evaluation of novel ammine/amine platinum (IV) dicarboxylates in L1210 murine leukaemia cells sensitive and resistant to cisplatin, tetraplatin or carboplatin. British Journal of Cancer. 70(3). 415–420. 17 indexed citations
18.
Findlay, Michael, David Cunningham, A. Norman, et al.. (1994). A phase II study in advanced gastro-esophageal cancer using epirubicin and cisplatin in combination with continuous infusion 5-fluorouracil (ECF). Annals of Oncology. 5(7). 609–616. 215 indexed citations
19.
Orr, Rosanne M., et al.. (1993). Evaluation of novel platinum (II), and platinum (IV) ammine/amine complexes in L1210 murine leukaemia cell lines sensitive and resistant to cisplatin and tetraplatin. 1(1). 17–23. 2 indexed citations
20.
Powles, T.J., et al.. (1992). Haemostatic changes and thromboembolic risk during tamoxifen therapy in normal women. British Journal of Cancer. 66(4). 744–747. 30 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Michitaka Nagase Breakdown of academic impact, for papers by U. Fink Breakdown of academic impact, for papers by Motonori Sairenji Breakdown of academic impact, for papers by D. P. Kelsen Breakdown of academic impact, for papers by John C. McAuliffe Breakdown of academic impact, for papers by Günther Klautke Breakdown of academic impact, for papers by Emmanuelle Samalin Breakdown of academic impact, for papers by Jacqui Oates Breakdown of academic impact, for papers by Seiichi Takagi Breakdown of academic impact, for papers by Aurore Blesius
Rankless by CCL
2026